Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis

被引：0
|
作者：
Ploumen, R. [1 ,2 ]
Claassens, E. [1 ]
Kooreman, L. [2 ,3 ]
Keymeulen, K. [1 ]
van Kats, M. [4 ]
Gommers, S.
Siesling, S. [6 ,7 ]
van Nijnatten, T. [2 ,5 ]
Smidt, M. [1 ,2 ]
机构：
[1] Maastricht Univ, Surg, Med Ctr, Maastricht, Netherlands
[2] GROW, Sch Oncol & Reprod, Maastricht, Netherlands
[3] Maastricht Univ, Pathol, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Oncol, Med Ctr, Maastricht, Netherlands
[5] Maastricht Univ, Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands
[6] Univ Twente, Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands
[7] Netherlands Comprehens Canc Org, Res & Dev, Utrecht, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 175卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1LBA
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [21] Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy
    Tina J. Hieken
    Judy C. Boughey
    Amy C. Degnim
    Katrina N. Glazebrook
    Tanya L. Hoskin
    Annals of Surgical Oncology, 2022, 29 : 5383 - 5386
  • [22] Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy
    Stjepanovic, Neda
    Kumar, Sudhir
    Jerzak, Katarzyna J.
    Trudeau, Maureen
    Warner, Ellen
    Cao, Xingshan
    Eisen, Andrea
    Tran, William
    Pezo, Rossanna C.
    CLINICAL BREAST CANCER, 2024, 24 (08) : e723 - e730
  • [23] Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy Reply
    Mukhtar, Rita A.
    Yau, Christina
    Esserman, Laura J.
    JAMA SURGERY, 2023, 158 (06) : 675 - 675
  • [24] Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients
    Chen, Zongshun
    Zhang, Jing
    Chen, Wei
    Chen, Xueyi
    Lu, Da-Lin
    Li, Junjie
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 4008 - 4016
  • [25] Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma
    Baretta, Zora
    Cruz Guindalini, Rodrigo Santa
    Khramtsova, Galina
    Olopade, Olufunmilayo I.
    CLINICAL BREAST CANCER, 2013, 13 (02) : 156 - 158
  • [26] Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
    Katayama, Ayaka
    Miligy, Islam M.
    Shiino, Sho
    Toss, Michael S.
    Eldib, Karim
    Kurozumi, Sasagu
    Quinn, Cecily M.
    Badr, Nahla
    Murray, Ciara
    Provenzano, Elena
    Callagy, Grace
    Martyn, Cian
    Millican-Slater, Rebecca
    Purdie, Colin
    Purnell, Dave
    Pinder, Sarah E.
    Oyama, Tetsunari
    Shaaban, Abeer M.
    Ellis, Ian
    Lee, Andrew H. S.
    Rakha, Emad A.
    MODERN PATHOLOGY, 2021, 34 (07) : 1271 - 1281
  • [27] Clinicopathological Factors Predicting Pathological Complete Response to Neoadjuvant Anti-HER2 Therapy in HER2-Positive Breast Cancer
    Jung, Youn Joo
    Lee, Seungju
    Kang, Seok Kyeong
    Kim, Jee Yeon
    Choo, Ki Seok
    Nam, Kyung Jin
    Joo, Ji Hyeon
    Kim, Jae Joon
    Kim, Hyun Yul
    ONCOLOGY, 2024,
  • [28] Use of MammaTyper® in predicting response to neoadjuvant therapy in HER2-positive breast cancer
    Scatena, C.
    Belcastro, E.
    Marletta, S.
    Tornabene, I.
    Cinacchi, P.
    Fontana, A.
    Martorana, F.
    Vigneri, P.
    Rizzo, A.
    Naccarato, A. G.
    BREAST, 2025, 80 : S78 - S79
  • [29] Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy
    Guiu, S.
    Reynier, M. A. Mouret
    Toure, M.
    Coudert, B.
    JOURNAL OF ONCOLOGY, 2013, 2013
  • [30] Pathological complete response and survival of HER2-positive invasive breast cancer following docetaxel, carboplatin, and trastuzumab neoadjuvant therapy: a Vietnamese experience
    Le, Duc Thanh
    Do, Tu Anh
    Bui, Lap Thanh
    Do, Kien Hung
    Nguyen, Chu Van
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (04): : 235 - 243
12345